BioCardia (BCDA) CEO Peter Altman Buys 800 Shares

What Happened

Peter Altman, President, CEO and a director of BioCardia, purchased 800 shares of BCDA stock in an open-market transaction on September 3, 2026. The reported weighted-average price was $1.09 per share, for a total reported cost of $872. This was a purchase (acquisition) rather than a sale, which some investors view as a modest affirmative signal by an insider.

Key Details

• Transaction date: 2026-09-03 (reported on Form 4 filed 2026-09-04)
• Transaction type/code: Open market purchase (P)
• Shares purchased: 800 shares
• Price: weighted average $1.09 per share (individual trades ranged $1.09–$1.10; reporter will provide per-trade details on request) — Footnote F1
• Total reported value: $872
• Correction note: Footnote F2 states 70 shares were added to correct an omission from a prior Form 4 filed Aug 18, 2026
• Shares owned after transaction: not specified in the provided filing text
• Timeliness: Filed one day after the transaction date (no late-filing indication in the provided data)

Context

• This is a small open-market purchase by an executive; purchases are often of greater interest than sales but the dollar amount here is modest.
• The filing includes a correction to a prior report (addition of 70 shares), which investors should note when reviewing historical insider activity for Altman.